Belapectin
Belapectin Uses, Dosage, Side Effects, Food Interaction and all others data.
Belapectin is under investigation in clinical trial NCT02575404 (GR-MD-02 Plus Pembrolizumab in Melanoma, Non-small Cell Lung Cancer, and Squamous Cell Head and Neck Cancer Patients).
Trade Name | Belapectin |
Generic | Belapectin |
Belapectin Other Names | Belapectin |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Belapectin